What does SOCIETE MEDICO-CHIRURGICALE L'ECTODERME do?

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is a specialist medical practice in Colfontaine. Private Limited, started on 23 September 2014, 1 establishment.

What is the address of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME?

The registered office of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is located at Rue de Binche 29, 7340 Colfontaine.

Is SOCIETE MEDICO-CHIRURGICALE L'ECTODERME still active?

Yes. According to the CBE (29 October 2026) SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is active, legal situation “Normale toestand”, started on 23 September 2014.

Is SOCIETE MEDICO-CHIRURGICALE L'ECTODERME registered on Peppol?

Yes, SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is registered on the Peppol network with ID 0208:0562894661.

What is the enterprise number of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME?

The enterprise number of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is BE0562894661.

When was SOCIETE MEDICO-CHIRURGICALE L'ECTODERME founded?

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME was founded on 23 September 2014.

Who are the directors of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME?

According to the 2025 annual accounts, the directors of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME are: Chadli OUAZZANI, Céline LECOCQ.

Is SOCIETE MEDICO-CHIRURGICALE L'ECTODERME a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 September 2014; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did SOCIETE MEDICO-CHIRURGICALE L'ECTODERME make in 2025?

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME posted a profit after taxes of € 59,039 in financial year 2025.

What is the revenue of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME?

As a small company, SOCIETE MEDICO-CHIRURGICALE L'ECTODERME is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 105,943.

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME (Private Limited)

Dossier SOCIETE MEDICO-CHIRURGICALE L'ECTODERME, printed on 29 October 2026 from databakkes.be/en/0562894661/societe-medico-chirurgicale-l-ectoderme. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME from Colfontaine, company number BE0562894661, closed financial year 2025 with a result of € 59,039 after tax. For that financial year SOCIETE MEDICO-CHIRURGICALE L'ECTODERME recorded a gross margin of € 105,943 and equity of € 159,580. Compared with financial year 2024, the result moved from € -7,740 to € 59,039. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 15, 2026.

What it is worth Growing

€ 159,580

▲ 59% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 59,039

▲ still € 7,740 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 112,199

▲ 182% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 140,980.

People and assets in 2025

Wage cost

€ 3,622

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 60,392

▲ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 140,168

▲ 235% vs 2024

€ 26,697 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 10,717

▲ 256% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,808

▲ 108% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 109,614 Gross margin 2022: € 109,614 First fiscal year in the series	€ 104,987 Gross margin 2023: € 104,987 ▼ 4% vs 2022 (€ 109,614) Unfavourable step	€ 25,189 Gross margin 2024: € 25,189 ▼ 76% vs 2023 (€ 104,987) Unfavourable step	€ 105,943 Gross margin 2025: € 105,943 ▲ € 80,753 vs 2024 (€ 25,189) Favourable step	▲ € 80,753
Profit after taxes	€ 69,394 Profit after taxes 2022: € 69,394 First fiscal year in the series	€ 47,596 Profit after taxes 2023: € 47,596 ▼ 31% vs 2022 (€ 69,394) Unfavourable step	€ -7,740 Profit after taxes 2024: € -7,740 ▼ € 55,336 vs 2023 (€ 47,596) Unfavourable step	€ 59,039 Profit after taxes 2025: € 59,039 ▲ € 66,779 vs 2024 (€ -7,740) Favourable step	▲ € 66,779
Equity	€ 135,685 Equity 2022: € 135,685 First fiscal year in the series	€ 108,281 Equity 2023: € 108,281 ▼ 20% vs 2022 (€ 135,685) Unfavourable step	€ 100,541 Equity 2024: € 100,541 ▼ 7% vs 2023 (€ 108,281) Unfavourable step	€ 159,580 Equity 2025: € 159,580 ▲ 59% vs 2024 (€ 100,541) Favourable step	▲ 59%
Total debts	€ 186,314 Total debts 2022: € 186,314 First fiscal year in the series	€ 178,788 Total debts 2023: € 178,788 ▼ 4% vs 2022 (€ 186,314) Favourable step	€ 118,178 Total debts 2024: € 118,178 ▼ 34% vs 2023 (€ 178,788) Favourable step	€ 233,228 Total debts 2025: € 233,228 ▲ 97% vs 2024 (€ 118,178) Unfavourable step	▲ 97%
Cash	€ 93,461 Cash 2022: € 93,461 First fiscal year in the series	€ 85,483 Cash 2023: € 85,483 ▼ 9% vs 2022 (€ 93,461) Unfavourable step	€ 39,841 Cash 2024: € 39,841 ▼ 53% vs 2023 (€ 85,483) Unfavourable step	€ 112,199 Cash 2025: € 112,199 ▲ 182% vs 2024 (€ 39,841) Favourable step	▲ 182%
Land & buildings	€ 77,594 Land & buildings 2022: € 77,594 First fiscal year in the series	€ 72,820 Land & buildings 2023: € 72,820 ▼ 6% vs 2022 (€ 77,594) Unchanged	€ 68,046 Land & buildings 2024: € 68,046 ▼ 7% vs 2023 (€ 72,820) Unchanged	€ 63,273 Land & buildings 2025: € 63,273 ▼ 7% vs 2024 (€ 68,046) Unchanged	▼ 7%
Retained profit	€ 117,085 Retained profit 2022: € 117,085 First fiscal year in the series	€ 89,681 Retained profit 2023: € 89,681 ▼ 23% vs 2022 (€ 117,085) Unfavourable step	€ 81,941 Retained profit 2024: € 81,941 ▼ 9% vs 2023 (€ 89,681) Unfavourable step	€ 140,980 Retained profit 2025: € 140,980 ▲ 72% vs 2024 (€ 81,941) Favourable step	▲ 72%
Dividend	€ 70,000 Dividend 2022: € 70,000 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 ▲ 7% vs 2022 (€ 70,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 75,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 88,216 Bank debt 2022: € 88,216 First fiscal year in the series	€ 65,191 Bank debt 2023: € 65,191 ▼ 26% vs 2022 (€ 88,216) Favourable step	€ 41,814 Bank debt 2024: € 41,814 ▼ 36% vs 2023 (€ 65,191) Favourable step	€ 140,168 Bank debt 2025: € 140,168 ▲ 235% vs 2024 (€ 41,814) Unfavourable step	▲ 235%
Balance sheet total	€ 321,999 Balance sheet total 2022: € 321,999 First fiscal year in the series	€ 287,068 Balance sheet total 2023: € 287,068 ▼ 11% vs 2022 (€ 321,999) Unchanged	€ 218,719 Balance sheet total 2024: € 218,719 ▼ 24% vs 2023 (€ 287,068) Unchanged	€ 392,808 Balance sheet total 2025: € 392,808 ▲ 80% vs 2024 (€ 218,719) Unchanged	▲ 80%

Key figures of SOCIETE MEDICO-CHIRURGICALE L'ECTODERME, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to SOCIETE MEDICO-CHIRURGICALE L'ECTODERME?

What happened at SOCIETE MEDICO-CHIRURGICALE L'ECTODERME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Chadli OUAZZANI stepped down as director. NBB
2026 Céline LECOCQ stepped down as director. NBB
Jan 15, 2026 New annual accounts for financial year 2025: profit of € 59,039. Source: NBB ↗
2023 Chadli OUAZZANI became a director. NBB
2023 Céline LECOCQ became a director. NBB
Sep 23, 2014 New establishment in Colfontaine. KBO
Sep 23, 2014 Start of the company according to the CBE. KBO

In short

From € 69,394 profit in 2022 to € 59,039 profit in 2025.

Paid € 47,694 in corporate taxes since 2022.

Best year ever: 2022, with € 69,394 profit.

Paid out € 145,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Chadli OUAZZANI

Director

since 2023 · until 2026

Céline LECOCQ

Director

Also active at: LECOUAZ IMMO

since 2023 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Binche 29

7340 Colfontaine

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

LECOUAZ IMMO same network

€ -2,657 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0562.894.661
VAT number: BE 0562.894.661
Registered office: Rue de Binche 29, 7340 Colfontaine
Names & denominations: SOCIETE MEDICO-CHIRURGICALE L'ECTODERME
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 September 2014
Peppol: Active · Active since 3 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

SOCIETE MEDICO-CHIRURGICALE L'ECTODERME